VASST
2008
Vasopressin and Septic Shock Trial
In 778 patients with septic shock on ≥5 µg/min norepinephrine, low-dose vasopressin added to norepinephrine did not reduce 28-day mortality compared with norepinephrine alone.
Result
- Absolute difference
- 3.9 points
The absolute difference is derived from the event rates.
Also reported: Less-severe subgroup 26.5% vs 35.7% (p=0.05; hypothesis-generating).
- Subtopic
- Vasopressors
- Design
- Double-blind RCT
- Relevance
- Important: one of several pillars.
- Source
- Russell JA, et al. N Engl J Med. 2008;358(9):877-887.doi 10.1056/NEJMoa067373
Discussion & critique
Vasopressin is a safe catecholamine-sparing adjunct; routine in most modern septic-shock protocols.